Results

Total Results: 968 records

Showing results for "calculate".

  1. effectivehealthcare-admin.ahrq.gov/products/methods-guidance-tests-decision-models/methods
    December 01, 2019 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …
  2. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-1-app-F.xlsx
    January 01, 2023 - F-1. Can. Study Characteristics Table F-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…
  3. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4-tables-E-1-E-4.xlsx
    January 01, 2023 - E-1. Can. Study Characteristics Table E-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…
  4. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-4-tables-F1-4.xlsx
    January 01, 2022 - F-1. Can. Study Characteristics Table F-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…
  5. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-3-tables-F1-4.xlsx
    January 01, 2022 - F-1. Can. Study Characteristics Table F-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…
  6. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/women-hiv_disposition-comments.pdf
    November 21, 2016 - Disposition of Comments for Technical Brief 29 Women Living With HIV-AIDS Source: https://www.effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports/ ?pageaction=displayproduct&productid=2328 Published Online: November 21, 2016 Technical Brief Disposition of Comments Report Research Rev…
  7. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/antiplatelet-treatment_research-protocol.pdf
    November 22, 2011 - Evidence-based Practice Center Systematic Review Protocol Source: www.effectivehealthcare.ahrq.gov Published Online: November 22, 2011 1 Evidence-based Practice Center Systematic Review Protocol Project Title: Testing of CYP2C19 Variants and Platelet Reactivity for Guiding Antiplatelet Treatment I. …
  8. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cad-women-diagnosis_executive.pdf
    June 01, 2012 - 1 Comparative Effectiveness Review Number 58 Noninvasive Technologies for the Diagnosis of Coronary Artery Disease in Women Executive Summary Background Cardiovascular disease is the leading cause of mortality for women in the United States.1 Coronary heart disease— which includes coronary artery (or atheroscl…
  9. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/registries-guide-2nd-edition_disposition-comments.pdf
    March 03, 2010 - to calculate an unbiased, generalizable adverse event rate associated with the exposure of interest,
  10. effectivehealthcare-admin.ahrq.gov/products/asthma-immunotherapy-2010/research-protocol
    December 01, 2020 - Measures of Treatment Effect We will calculate summary risk ratios or odds ratios as appropriate for … We will verify normality of continuous outcomes and calculate mean differences; standardized mean differences
  11. effectivehealthcare-admin.ahrq.gov/products/prostate-cancer-test/research-protocol
    December 01, 2019 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …
  12. effectivehealthcare-admin.ahrq.gov/sites/default/files/product/pdf/mmm-draft-protocol-amendment.pdf
    February 02, 2022 - When appropriate, we will synthesize data using random effects models and will calculate odds ratios
  13. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/bladder-cancer-non-muscle-invasive_executive.pdf
    October 01, 2015 - 1 Comparative Effectiveness Review Number 153 Emerging Approaches to Diagnosis and Treatment of Non–Muscle-Invasive Bladder Cancer Executive Summary Background Bladder cancer is the 4th most commonly diagnosed cancer in men and the 10th most commonly diagnosed cancer in women in the United States.1 The Ameri…
  14. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/traumatic-brain-injury-rehabilitation-future_research.pdf
    January 01, 2013 - Multidisciplinary Rehabilitation Programs for Moderate to Severe Traumatic Brain Injury in Adults: Future Research Needs Future Research Needs Paper Number 36 Multidisciplinary Rehabilitation Programs for Moderate to Severe Traumatic Brain Injury in Adults: Future Research Needs Future Research Needs Paper N…
  15. Layout 1 (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/acs-pci-adjunctive-devices_executive.pdf
    December 01, 2011 - Layout 1 Background Coronary stents and adjunctive pharmacologic agents—including glycoprotein IIb/IIIa receptor inhibitors and thienopyridines—have improved the efficacy of percutaneous coronary intervention (PCI).1,2 However, dislodgement of atherothrombotic material from coronary lesions during PCI can result in …
  16. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-guidance-grading-evidence_methods.pdf
    November 01, 2013 - challenging when 20 some studies in the evidence base do not report (or reviewers cannot independently calculate
  17. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/transparency-mental-health_research-protocol.pdf
    September 01, 2016 - Transparency of Reporting Requirements: Strategies to Improve Mental Health Care for Children and Adolescents Source: www.effectivehealthcare.ahrq.gov Published online: September 1, 2016 Evidence-based Practice Center Methodology Report Protocol Project Title: Transparency of Reporting Requirements Rep…
  18. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/celiac-disease_clinician.pdf
    July 01, 2016 - Diagnosis of Celiac Disease: Current State of the Evidence Diagnosis of Celiac Disease: Current State of the Evidence Background Focus of This Summary This is a summary of a systematic review evaluating the evidence regarding the comparative accuracy (the balance of sensitivity and specificity) and possible adv…
  19. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/Appendix-E-Evidence-Tables-E1-E4_0.xlsx
    November 04, 2021 - E-1. Can. Study Characteristics Table E-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race, Hispanic/Latino % Race, Asian % Race, Other % P…
  20. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-protocol_amended110619.pdf
    November 02, 2019 - We will calculate risk ratios (RR) and absolute risk differences (RD) with the corresponding 95 percent

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: